Cover Image
市場調查報告書

分子診斷的歐洲市場 (各技術、各用途) - 產業分析、規模、佔有率、成長、趨勢、2015∼2023年的預測

Molecular Diagnostics Market (Product - Real-time PCR Systems, Liquid Handling Systems, and DNA Extraction Systems; End User) - Europe Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2017 - 2025

出版商 Transparency Market Research 商品編碼 354779
出版日期 內容資訊 英文 93 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
分子診斷的歐洲市場 (各技術、各用途) - 產業分析、規模、佔有率、成長、趨勢、2015∼2023年的預測 Molecular Diagnostics Market (Product - Real-time PCR Systems, Liquid Handling Systems, and DNA Extraction Systems; End User) - Europe Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2017 - 2025
出版日期: 2017年05月31日 內容資訊: 英文 93 Pages
簡介

本報告提供歐洲的分子診斷市場相關調查,市場現狀與今後的預測,各技術及各用途趨勢,各地區趨勢,及打入市場的主要企業簡介等彙整資料。

第1章 序論

第2章 摘要整理

第3章 歐洲的分子診斷市場:產業分析

  • 簡介
  • 促進要素
    • 歐洲的慢性及感染疾病的罹患率上升
    • 搭配診斷及個人化醫療的認識度提高
  • 阻礙要素
    • 償付政策相關問題
  • 機會
    • 技術的進步成為持續成長的機會
  • 波特五力分析
  • 市場魅力度分析
  • 市場魅力度分析:各地區
  • 市場魅力度分析:各技術
  • 市場魅力度分析:各用途
  • 患者群分析:各感染疾病
  • 患者群分析:各癌症
  • 患者群分析:各心血管疾病
  • 企業的市場佔有率
  • 競爭環境
  • 合併、收購

第4章 市場區隔:各技術

  • 簡介
  • 聚合酵素鏈鎖反應
  • 混合化
  • 質譜分析
  • 轉印媒介放大
  • 次世代定序
  • 生物晶片及微流體
  • 其他

第5章 市場區隔:各用途

  • 簡介
  • 癌症
  • 感染疾病
  • 病毒
  • 細菌學
  • 基因學
  • 血液檢驗
  • 婦產科
  • 微生物學
  • 產前及新生兒篩檢

第6章 歐洲的分子診斷市場:各地區分析

  • 北歐
  • 東歐
  • 西歐
  • 南歐
  • 其他

第7章 現狀及歷史概要

第8章 企業簡介

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Alere, Inc.
  • Affymetrix, Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Cepheid, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Meridian Bioscience, Inc.
  • PerkinElmer, Inc.
  • Randox Laboratories, Ltd.
  • QIAGEN N.V.
  • Siemens AG
  • Thermo Fisher Scientific, Inc.

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Europe Molecular Diagnostics Market: Overview

Molecular diagnostics market employs a range of systems, including real-time PCR systems, liquid handling systems, and DNA extraction systems, among others. Real-time PCR systems are commonly known as quantitative PCR systems. These systems monitor the amplification of the targeted DNA molecule during the exponential phase. The commonly used detection methods in these systems include fluorescent dyes and sequence specific DNA probes. The basic components of these systems include thermal cycler for automating the temperature cycling required in the PCR; optical systems for detection; and software to control the instrument and analyze the data. Liquid handling systems are used to dispense selected quantity of reagents, liquids, or samples to a container. These systems work on the principle of suction and are available as single or multi-channel systems. DNA Extraction systems are employed for streamlining the process of DNA extraction and automatic extraction of DNA from a variety of samples. These systems are employed as they are less time consuming, more efficient than the manual methods, and less prone to analytical errors.

Europe Molecular Diagnostics Market: Research Methodologies

The research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue and volume of molecular diagnostics systems in the near future. Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentation and various international and national databases. The report provides estimated market size in terms of US$ Mn and volume in terms of units for each products and end-user. In addition, the report provides estimated market size in terms of US$ Mn for various geographic regions in Europe for the period 2015 to 2025, considering the macro and micro environmental factors. The revenue generated from each product was calculated by considering their launch date in the market, customer acceptance, volume sales, price of the product, trends in industry, end user trend, and adoption rate across all the geographies.

The market report comprises an elaborated executive summary, which includes market snapshot that provides information about various segments of the market. It also provides information and data analysis of the market with respect to market segments based on product, end-user, and geography. The market overview section of the report analyzes market dynamics such as drivers, restraints and opportunities that influences the molecular diagnostics market in the current and future scenario. The report also provides value chain analysis of the market that describes the sequence of activities involved from identification of the market need to their final reach to the end users.

Market share analysis among the market players is analyzed to signify the contribution of these players in the market in terms of percentage share. All these factors will help the market players to decide about the business strategies and plans to strengthen their positions in the Europe market. Based on geography, the market has been analyzed for major countries: U.K. France, Germany, Italy, Spain, and Rest of Europe.

Key Players Mentioned in this Report are:

  • The report also profiles the major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the Europe molecular diagnostics market report are Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, Eppendorf AG, F. Hoffmann-La Roche Ltd., PerkinElmer, Inc., QIAGEN N.V., Tecan Group Ltd., and Thermo Fisher Scientific, Inc. among others.

The Molecular Diagnostics Market has been segmented as follows:

  • Molecular Diagnostics Market, by Product, Revenue (US$ Mn) and Volume (units) 2015-2025
  • Real Time- PCR Systems
  • LightCycler 480
  • PCRmax Eco 48
  • Applied Biosystems 7900HT
  • QuantStudio Real-Time PCR
  • ViiA 7 Real-Time PCR
  • C1000 Touch
  • ABI StepOnePlus Real-Time PCR
  • 5ABI 7500
  • AriaMx Real-time PCR System
  • CFX Connect
  • CFX384 Touch
  • MiniOpticon
  • Others
  • Liquid Handling System
  • epMotion
  • Biomek
  • Freedom EVO
  • Tecan D300e Digital Dispenser
  • Precision
  • JANUS
  • Others
  • DNA Extraction System
  • AutoMate Express
  • QIAcube
  • InnuPure
  • VERSA
  • chemagic
  • Others
  • Molecular Diagnostics Market, by End-User, Revenue (US$ Mn) and Volume (units) 2015-2025
  • Hospitals
  • Diagnostic Laboratories
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Molecular Diagnostics Market, by Country, Revenue (US$ Mn) 2015-2025
  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Europe Molecular Diagnostics Market

4. Market Overview

  • 4.1. Introduction
  • 4.2. Key Market Indicators
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunity
  • 4.4. Europe Molecular Diagnostics Market Analysis and Forecasts, 2015-2025
    • 4.4.1. Market Revenue (US$ Mn) and Volume (units) Projections
    • 4.4.2. Installed Base- Global (units)
  • 4.5. Porter's Five Force Analysis
  • 4.6. Value Chain Analysis
  • 4.8. Regulatory approval process
  • 4.9. Market Outlook

5. Europe Molecular Diagnostics Market Analysis and Forecasts, By Product

  • 5.1. Introduction & Definition
  • 5.2. Key Findings / Developments
  • 5.3. Key Trends
  • 5.4. Market Size (US$ Mn) and Volume (Units) Forecast, By Product
    • 5.4.1. Real Time- PCR Systems
      • 5.4.1.1. LightCycler 480
      • 5.4.1.2. PCRmax Eco 48
      • 5.4.1.3. Applied Biosystems 7900HT
      • 5.4.1.4. QuantStudio Real-Time PCR
      • 5.4.1.5. ViiA 7 Real-Time PCR
      • 5.4.1.6. C1000 Touch
      • 5.4.1.7. ABI StepOnePlus Real-Time PCR
      • 5.4.1.8. ABI 7500
      • 5.4.1.9. AriaMx Real-time PCR System
      • 5.4.1.10. CFX Connect
      • 5.4.1.11. CFX384 Touch
      • 5.4.1.12. MiniOpticon
      • 5.4.1.13. Others
    • 5.4.2. Liquid Handling System
      • 5.4.2.1. epMotion
      • 5.4.2.2. Biomek
      • 5.4.2.3. Freedom EVO
      • 5.4.2.4. Tecan D300e Digital Dispenser
      • 5.4.2.5. Precision
      • 5.4.2.6. JANUS
      • 5.4.2.7. Others
    • 5.4.3. DNA Extraction System
      • 5.4.3.1. AutoMate Express
      • 5.4.3.2. QIAcube
      • 5.4.3.3. InnuPure
      • 5.4.3.4. VERSA
      • 5.4.3.5. chemagic
      • 5.4.3.6. Others
  • 5.5. Market Attractiveness, By Product

6. Europe Molecular Diagnostics Market Analysis and Forecasts, By End-user

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Key Trends
  • 6.4. Market Size (US$ Mn) and volume (units) Forecast, By End-user
    • 6.4.1. Hospital
    • 6.4.2. Diagnostics Laboratories
    • 6.4.3. Academics & Research Institutes
    • 6.4.4. Pharmaceutical & Biotechnology Companies
  • 6.5. Market Attractiveness By End-user

7. Molecular Diagnostics Market Analysis and Forecasts, By Country

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Size (US$ Mn) Forecast, By Country
    • 7.3.1. U.K.
    • 7.3.2. France
    • 7.3.3. Germany
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Rest of Europe
  • 7.4. Market Attractiveness By Country

8. Competition Landscape

  • 8.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 8.2. Market Share Analysis By Company (2016)
  • 8.3. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)
    • 8.3.1. Agilent Technologies, Inc.
      • 8.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 8.3.1.2. Business Overview
      • 8.3.1.3. Product Portfolio
      • 8.3.1.4. Financial Overview
      • 8.3.1.5. SWOT Analysis
      • 8.3.1.6. Strategic overview
    • 8.3.2. Becton, Dickinson and Company
      • 8.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 8.3.2.2. Business Overview
      • 8.3.2.3. Product Portfolio
      • 8.3.2.4. Financial Overview
      • 8.3.2.5. SWOT Analysis
      • 8.3.2.6. Strategic overview
    • 8.3.3. Bio-Rad Laboratories, Inc.
      • 8.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 8.3.3.2. Business Overview
      • 8.3.3.3. Product Portfolio
      • 8.3.3.4. Financial Overview
      • 8.3.3.5. SWOT Analysis
      • 8.3.3.6. Strategic overview
    • 8.3.4. Danaher Corporation
      • 8.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 8.3.4.2. Business Overview
      • 8.3.4.3. Product Portfolio
      • 8.3.4.4. Financial Overview
      • 8.3.4.5. SWOT Analysis
      • 8.3.4.6. Strategic overview
    • 8.3.5. Eppendorf AG
      • 8.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 8.3.5.2. Business Overview
      • 8.3.5.3. Product Portfolio
      • 8.3.5.4. Financial Overview
      • 8.3.5.5. SWOT Analysis
      • 8.3.5.6. Strategic overview
    • 8.3.6. F. Hoffmann-La Roche Ltd.
      • 8.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 8.3.6.2. Business Overview
      • 8.3.6.3. Product Portfolio
      • 8.3.6.4. Financial Overview
      • 8.3.6.5. SWOT Analysis
      • 8.3.6.6. Strategic overview
    • 8.3.7. PerkinElmer, Inc.
      • 8.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 8.3.7.2. Business Overview
      • 8.3.7.3. Product Portfolio
      • 8.3.7.4. Financial Overview
      • 8.3.7.5. SWOT Analysis
      • 8.3.7.6. Strategic overview
    • 8.3.8. QIAGEN N.V.
      • 8.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 8.3.8.2. Business Overview
      • 8.3.8.3. Product Portfolio
      • 8.3.8.4. Financial Overview
      • 8.3.8.5. SWOT Analysis
      • 8.3.8.6. Strategic overview
    • 8.3.9. Tecan Group Ltd.
      • 8.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 8.3.9.2. Business Overview
      • 8.3.9.3. Product Portfolio
      • 8.3.9.4. Financial Overview
      • 8.3.9.5. SWOT Analysis
      • 8.3.9.6. Strategic overview
    • 8.3.10. Thermo Fisher Scientific, Inc.
      • 8.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 8.3.10.2. Business Overview
      • 8.3.10.3. Product Portfolio
      • 8.3.10.4. Financial Overview
      • 8.3.10.5. SWOT Analysis
      • 8.3.10.6. Strategic overview

List of Tables

  • Table 01: Europe Molecular Diagnostics Market Size (US$ Mn) and Volume (Units) Forecast, by Product, 2017-2025
  • Table 02: Europe Molecular Diagnostics Market Size (US$ Mn) and Volume (Units) Forecast, by Product - Real-time PCR Systems, 2017-2025
  • Table 03: Europe Molecular Diagnostics Market Size (US$ Mn) and Volume (Units) Forecast, by Product - Liquid Handling Systems, 2017-2025
  • Table 04: Europe Molecular Diagnostics Market Size (US$ Mn) and Volume (Units) Forecast, by Product - DNA Extraction Systems, 2017-2025
  • Table 05: Europe Molecular Diagnostics Market Size (US$ Mn) and Volume (Units) Forecast, by End-user, 2015-2025
  • Table 06: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country, 2017-2025

List of Figures

  • Figure 01: Europe Molecular Diagnostics Market Size (US$ Mn) and Volume (units), and Forecast, 2017-2025
  • Figure 02: Market Value Share By Product (2017)
  • Figure 03: Market Value Share By End-user (2017)
  • Figure 04: Market Value Share By Country (2017)
  • Figure 05: Europe Molecular Diagnostics Market Value Share Analysis, by Product, 2016 and 2025
  • Figure 06: Europe Real-time PCR Systems Market Revenue (US$ Mn) and Volume (Units), 2015-2025
  • Figure 07: Europe Liquid Handling Systems Market Revenue (US$ Mn) and Volume (Units), 2015-2025
  • Figure 08: Europe DNA Extraction Systems Market Revenue (US$ Mn) and Volume (Units), 2015-2025
  • Figure 09: Europe Molecular Diagnostics Market Attractiveness Analysis, by Product
  • Figure 10: Europe Molecular Diagnostics Market Value Share Analysis, by End-user, 2016 and 2025
  • Figure 11: Europe Hospitals Market Revenue (US$ Mn) and Volume (Units) 2015-2025
  • Figure 12: Europe Diagnostic Laboratories Market Revenue (US$ Mn) and Volume (Units), 2015-2025
  • Figure 13: Europe Academic and Research Institutes Market Revenue (US$ Mn) and Volume (Units), 2015-2025
  • Figure 14: Europe Pharmaceutical and Biotechnology Companies Market Revenue (US$ Mn) and Volume (Units), 2015-2025
  • Figure 15: Molecular Diagnostics Market Attractiveness Analysis, by End-user
  • Figure 16: Europe Molecular Diagnostics Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 17: Europe Molecular Diagnostics Market Attractiveness Analysis, by Country
  • Figure 18: Europe Molecular Diagnostics Market Share Analysis, by Company (2016)
Back to Top